- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1780EUR$2,000USD£1,549GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2226EUR$2,500USD£1,936GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1780EUR$2,000USD£1,549GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1335EUR$1,500USD£1,162GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1335EUR$1,500USD£1,162GBP
- Report
- May 2025
- 185 Pages
Global
From €4006EUR$4,500USD£3,485GBP
- Report
- March 2025
- 180 Pages
Global
From €4006EUR$4,500USD£3,485GBP
- Report
- March 2025
- 187 Pages
Global
From €4006EUR$4,500USD£3,485GBP
- Report
- February 2025
- 185 Pages
Global
From €4006EUR$4,500USD£3,485GBP
- Report
- March 2025
- 185 Pages
Global
From €4006EUR$4,500USD£3,485GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1780EUR$2,000USD£1,549GBP
- Report
- August 2025
- 150 Pages
Global
From €2989EUR$3,358USD£2,600GBP
€3516EUR$3,950USD£3,059GBP
- Report
- August 2025
- 150 Pages
Global
From €2989EUR$3,358USD£2,600GBP
€3516EUR$3,950USD£3,059GBP
- Report
- July 2025
- 350 Pages
Global
From €4406EUR$4,949USD£3,833GBP
- Report
- July 2025
- 350 Pages
Global
From €4406EUR$4,949USD£3,833GBP
- Report
- January 2025
- 250 Pages
Global
From €4450EUR$4,999USD£3,871GBP
- Report
- June 2025
- 150 Pages
Global
From €2403EUR$2,699USD£2,090GBP
- Report
- June 2025
- 200 Pages
Global
From €2483EUR$2,789USD£2,160GBP
- Report
- January 2025
- 54 Pages
Global
From €2225EUR$2,499USD£1,935GBP
- Report
- July 2025
- 80 Pages
United States
From €5297EUR$5,950USD£4,608GBP

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient.
The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more